Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment.
Saved in:
| Title: | Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment. |
|---|---|
| Authors: | Mijangos LRR; National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, UK., Harding SE; National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, UK., Darton NJ; Dosage Form Design and Development, AstraZeneca, BioPharmaceuticals R&D, 1 Francis Crick Avenue, Cambridge, Cambridgeshire CB2 0AA UK. |
| Source: | Biophysical reviews [Biophys Rev] 2025 Aug 02; Vol. 17 (4), pp. 1013-1031. Date of Electronic Publication: 2025 Aug 02 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 101498573 Publication Model: eCollection Cited Medium: Print ISSN: 1867-2450 (Print) Linking ISSN: 18672450 NLM ISO Abbreviation: Biophys Rev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1867-2450 |
|---|---|
| DOI: | 10.1007/s12551-025-01346-2 |
